Pharmaceutical control of cardiovascular risk factors in HIV patients: drug interactions to consider

被引：0
|
作者：
Bergmann, Martin W. [1 ]
Eschenhagen, Thomas [2 ]
机构：
[1] Cardiol Hamburg, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Expt Pharmakol & Toxikol, Hamburg, Germany
来源：
KARDIOLOGE | 2020年 / 14卷 / 01期
关键词：
D O I：
10.1007/s12181-019-00367-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [41] Prevalence and control of cardiovascular risk factors in hypertensive renal transplant patients
    Izhar, M
    Nambiar, R
    Hasabou, N
    Jensik, S
    Neri, G
    Elliott, WJ
    Black, HR
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 245A - 245A
  • [42] Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease
    Hawkins, Nathaniel M.
    Peterson, Sandra
    Ezzat, Allison M.
    Vijh, Rohit
    Virani, Sean A.
    Gibb, Andrew
    Mancini, G. B. John
    Wong, Sabrina T.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (07) : 1102 - 1111
  • [43] CONTROL OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH SPONDYLOARTHROPATHIES VERSUS RHEUMATOID ARTHRITIS
    Desmet, C.
    Ursachi, V.
    Manolache, N. G.
    Toukap, A. Nzeusseu
    Stoenoiu, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1717 - 1718
  • [44] Cardiovascular risk factors and 10-years probability for cardiovascular events in HIV-infected patients
    Neumann, T
    Woiwod, T
    Miller, M
    Volbracht, L
    Brockmeyer, N
    Erbel, R
    EUROPEAN HEART JOURNAL, 2003, 24 : 447 - 447
  • [45] Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome
    Pejcic, Ana, V
    Jankovic, Slobodan M.
    Davidovic, Goran
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [46] Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease
    Harvey, Ronee E.
    Coffman, Kirsten E.
    Miller, Virginia M.
    WOMENS HEALTH, 2015, 11 (02) : 239 - 257
  • [47] Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease
    Stojadinovic, Dobrivoje
    Zaric, Radica Zivkovic
    Jankovic, Slobodan
    Lazic, Zorica
    Cekerevac, Ivan
    Susa, Romana
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 1123 - 1125
  • [48] Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors
    Bibi, Rashida
    Azhar, Saira
    Iqbal, Ayesha
    Jabeen, Hajera
    Kalsoom, Umm-e
    Iqbal, Muhammad M.
    Nazeer, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1616 - 1622
  • [49] Risk factors for contraindicated potential drug-drug interactions in acute intracerebral hemorrhage patients
    Aleksic, D.
    Toncev, G.
    Drakulic, S. Miletic
    Milosavljevic, M.
    Jankovic, S.
    Stefanovic, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 363 - 363
  • [50] Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease
    Dobrivoje Stojadinovic
    Radica Zivkovic Zaric
    Slobodan Jankovic
    Zorica Lazic
    Ivan Cekerevac
    Romana Susa
    Irish Journal of Medical Science (1971 -), 2020, 189 : 1123 - 1125
12345